Tokyo Tape
Sign in
← Kidswell Bio

Quarterly report · Q2

4584.TEDINET S100SALZ
Period2023-04-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥582m2023-04-01 → 2023-09-30StandaloneNet sales
Revenue¥2.8bn2022-04-01 → 2023-03-31StandaloneNet sales (5-year summary)
Revenue¥1.1bn2022-04-01 → 2022-09-30StandaloneNet sales
Operating income−¥720m2023-04-01 → 2023-09-30StandaloneOperating income
Operating income¥11m2022-04-01 → 2022-09-30StandaloneOperating income
Ordinary income−¥745m2023-04-01 → 2023-09-30StandaloneOrdinary income
Ordinary income−¥625m2022-04-01 → 2023-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥42m2022-04-01 → 2022-09-30StandaloneOrdinary income
Profit before tax−¥780m2023-04-01 → 2023-09-30StandaloneIncome before income taxes
Profit before tax−¥42m2022-04-01 → 2022-09-30StandaloneIncome before income taxes
Net income−¥780m2023-04-01 → 2023-09-30StandaloneProfit loss
Net income−¥657m2022-04-01 → 2023-03-31StandaloneNet income loss (5-year summary)
Net income−¥43m2022-04-01 → 2022-09-30StandaloneProfit loss
Total assets¥3.2bnat 2023-09-30StandaloneAssets
Total assets¥3.9bnat 2023-03-31StandaloneAssets
Total assets¥4.3bnat 2022-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥2.1bnat 2023-09-30StandaloneLiabilities
Total liabilities¥2.7bnat 2023-03-31StandaloneLiabilities
Net assets / equity¥1.1bnat 2023-09-30StandaloneNet assets
Net assets / equity¥1.2bnat 2023-03-31StandaloneNet assets
Net assets / equity¥1.7bnat 2022-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥622mat 2023-09-30StandaloneCash and deposits
Cash and deposits¥1.1bnat 2023-03-31StandaloneCash and deposits
Cash & equivalents¥622mat 2023-09-30StandaloneCash and cash equivalents
Cash & equivalents¥1.1bnat 2023-03-31StandaloneCash and cash equivalents
Cash & equivalents¥1.9bnat 2022-09-30StandaloneCash and cash equivalents
Cash & equivalents¥1.2bnat 2022-03-31dStandaloneCash and cash equivalents
Operating cash flow−¥877m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.4bn2022-04-01 → 2023-03-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥709m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥29m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥24m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥432m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥1.4bn2022-04-01 → 2023-03-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.4bn2022-04-01 → 2022-09-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-24.12023-04-01 → 2023-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-9.292023-07-01 → 2023-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-20.772022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-1.362022-04-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥1.222022-07-01 → 2022-09-30dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio27.9%at 2023-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio26.6%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio35.2%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued35,837,613at 2023-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued32,059,713at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued31,471,147at 2022-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 386
ItemContextValueUnit
Retained earningsCurrentQuarterInstant_NonConsolidatedMember-12067255000JPY
Treasury stockPrior1YearInstant_NonConsolidatedMember-73000JPY
Treasury stockCurrentQuarterInstant_NonConsolidatedMember-73000JPY
Shareholders equityPrior1YearInstant_NonConsolidatedMember1037518000JPY
Shareholders equityCurrentQuarterInstant_NonConsolidatedMember892512000JPY
Subscription rights to sharesPrior1YearInstant_NonConsolidatedMember195987000JPY
Subscription rights to sharesCurrentQuarterInstant_NonConsolidatedMember182600000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember1233505000JPY
Net assetsCurrentQuarterInstant_NonConsolidatedMember1075113000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember3894765000JPY
Liabilities and net assetsCurrentQuarterInstant_NonConsolidatedMember3193837000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember1116111000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember581870000JPY
Cost of salesPrior1YTDDuration_NonConsolidatedMember420954000JPY
Cost of salesCurrentYTDDuration_NonConsolidatedMember351901000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember695156000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember229968000JPY
Research and development expenses sgaPrior1YTDDuration_NonConsolidatedMember251787000JPY
Research and development expenses sgaCurrentYTDDuration_NonConsolidatedMember546693000JPY
Other sgaPrior1YTDDuration_NonConsolidatedMember432230000JPY
Other sgaCurrentYTDDuration_NonConsolidatedMember402933000JPY
Selling general and administrative expensesPrior1YTDDuration_NonConsolidatedMember684018000JPY
Selling general and administrative expensesCurrentYTDDuration_NonConsolidatedMember949627000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember11137000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember-719658000JPY
Interest income noiPrior1YTDDuration_NonConsolidatedMember5000JPY
Interest income noiCurrentYTDDuration_NonConsolidatedMember3000JPY
Gain on sales of materials noiPrior1YTDDuration_NonConsolidatedMember2250000JPY
Gain on sales of materials noiCurrentYTDDuration_NonConsolidatedMember2289000JPY
Miscellaneous income noiPrior1YTDDuration_NonConsolidatedMember360000JPY
Miscellaneous income noiCurrentYTDDuration_NonConsolidatedMember7000JPY
Non operating incomePrior1YTDDuration_NonConsolidatedMember2615000JPY
Non operating incomeCurrentYTDDuration_NonConsolidatedMember2299000JPY
Interest expenses noePrior1YTDDuration_NonConsolidatedMember13664000JPY
Interest expenses noeCurrentYTDDuration_NonConsolidatedMember18842000JPY
Interest on bonds noePrior1YTDDuration_NonConsolidatedMember676000JPY
Interest on bonds noeCurrentYTDDuration_NonConsolidatedMember1836000JPY
Stock issuance cost noePrior1YTDDuration_NonConsolidatedMember389000JPY
Stock issuance cost noeCurrentYTDDuration_NonConsolidatedMember1277000JPY
Commission fee noePrior1YTDDuration_NonConsolidatedMember30000000JPY
Commission fee noeCurrentYTDDuration_NonConsolidatedMember－JPY
Foreign exchange losses noePrior1YTDDuration_NonConsolidatedMember10553000JPY
Foreign exchange losses noeCurrentYTDDuration_NonConsolidatedMember4813000JPY
Miscellaneous loss noePrior1YTDDuration_NonConsolidatedMember551000JPY
Miscellaneous loss noeCurrentYTDDuration_NonConsolidatedMember517000JPY
Non operating expensesPrior1YTDDuration_NonConsolidatedMember55835000JPY
Non operating expensesCurrentYTDDuration_NonConsolidatedMember27287000JPY
Ordinary incomePrior1YTDDuration_NonConsolidatedMember-42082000JPY
Ordinary incomeCurrentYTDDuration_NonConsolidatedMember-744646000JPY
Loss on valuation of investment securities elPrior1YTDDuration_NonConsolidatedMember－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2023-03-31pass rounding
balance sheet identitynon_consolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2023-09-30pass
statement vs summary · operating cash flownon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flownon_consolidated 2023-04-01/2023-09-30pass
statement vs summary · revenuenon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2023-09-30pass